Episode 87

Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 1

Featuring perspectives from Dr Mazyar Shadman, including the following topics:

  • The CLL17 trial: Fixed-duration versus continuous targeted treatment for previously untreated chronic lymphocytic leukemia (CLL) (0:00)
  • The AMPLIFY trial: Fixed-duration acalabrutinib combinations for untreated CLL (5:31)
  • Zanubrutinib-based therapy for treatment-naïve CLL (12:32)

CME information and select publications

All Episodes Previous Episode

About the Podcast

Show artwork for Hematologic Oncology Update
Hematologic Oncology Update
This series bridges the gap between research and patient care by providing medical oncologists with access to important information on relevant advances in the treatment of hematologic malignancies.

Listen for free